|

Obsessive-Compulsive
Disorder
Obsessive-compulsive disorder (OCD) is an anxiety disorder
characterized by obsessions that cause marked anxiety or
distress and/or by compulsions that serve to neutralize
anxiety. Symptoms may be mild but merely annoying or may
disable a person throughout a lifetime.
Obsessions are persistent ideas, thoughts, impulses, or
images that are experienced as intrusive and inappropriate and
that cause marked anxiety or distress. The most common
obsessions are repeated thoughts about contamination (that is,
becoming contaminated by germs or by shaking hands); repeated
doubts (wondering whether one has performed some act, such as
having left a door unlocked or a coffee pot brewing on the
stove); a need to have things in a particular order;
aggressive or horrific impulses (which the person might never
act on); or sexual imagery that is inappropriate or
frightening.
Compulsions are repetitive behaviors (hand washing,
checking) or mental acts (praying, counting, repeating words
silently). The goal of compulsions is to prevent or reduce
anxiety or distress. The person feels driven to perform the
compulsion to reduce the distress caused by the obsessive
thought.
Many people may consider themselves to be compulsive
because they hold themselves to a high standard of performance
and are perfectionist and highly organized in work and
recreational activities. This type of compulsiveness often is
an attribute that contributes to a person's self-esteem and
success.
People who have been clinically diagnosed with OCD suffer
from obsessive and compulsive behaviors that are extreme
enough to interfere with their everyday lives. The obsessions
and compulsions these people experience can ruin their
lives.
Incidence of OCD
For a long time, mental health professionals considered OCD
to be a rare condition. That may be because OCD often has gone
unrecognized. Many people who suffer from OCD are ashamed of
their irrational behaviors and try to keep their problem a
secret. But in recent years, as science has confirmed that OCD
is a potentially severe anxiety disorder, more people have
begun to seek treatment.
OCD, in fact, affects more than 2.3% of the U.S. population
between the ages of 18-54, according to the National Institute
of Mental Health (NIMH). According to the Mayo Clinic, an
estimated 3.3 million Americans have obsessive-compulsive
disorder. That makes OCD more common than schizophrenia,
bipolar disorder, or panic disorder. In addition, OCD is an
"equal opportunity" illness, striking people of all ages,
gender, and ethnic groups.
OCD's impact on society is enormous. In 1990, in the United
States alone, OCD resulted in social and economic losses of
more than $8.4 billion--nearly 6% of the nation's total mental
health bill of $148 billion (National Institute of Mental
Health (NIMH) www.nimh.nih.gov/anxiety/ocdfacts.cfm).
What Causes OCD?
Psychiatrists once thought that OCD was caused by traumatic
past events in a person's life. A person with OCD, for
example, might have learned as a child to overemphasize
cleanliness or to develop a belief that certain thoughts were
dangerous or unacceptable.
Now a growing body of research indicates that biological
factors and/or cognitive processes may cause or contribute to
the disorder. Many OCD patients, for example, respond well to
medications that alter brain chemistry. Tendencies to develop
OCD may be inherited: the condition has been known to run in
families. And there is evidence that OCD involves
abnormalities in brain chemistry.
To identify biological factors that may be relevant in
onset or development of OCD, NIMH researchers used a device
called a positron emission tomography (PET) scanner to study
brains of OCD patients.
The investigators found that OCD patients exhibit brain
activity that differs from that of people who do not suffer
from mental illness, or who have mental problems other than
OCD. Researchers found that OCD patients exhibited abnormal
neurochemical activity in brain regions known to play a role
in certain neurological disorders.
Other recent studies using magnetic resonance imaging (MRI)
technology found that subjects with OCD had significantly less
white brain matter than normal control subjects did.
Even if there is a biological basis for OCD, that doesn't
mean that a person's environment, beliefs, and attitudes are
not also linked to the disease. In addition, people with OCD
may process information differently from those who do not have
the illness.
How OCD is ManifestED
Traditionally, OCD was thought to show up during teenage
years or in early adulthood. But new research indicates that
some children develop the illness as early as preschool. In
fact, a third of all OCD cases may begin in childhood.
The essential features of obsessive-compulsive disorder are
recurrent obsessions or compulsions that are severe enough to
be time-consuming (taking more than 1 hour a day) or that
cause marked distress or significant impairment. Usually at
some point during the course of the disorder, the person
recognizes that the obsessions or compulsions are excessive or
unreasonable, but is powerless to change behavior without
intervention.
OCD is sometimes accompanied by other psychological
problems, including depression, eating disorders, substance
abuse disorder, personality disorder, attention deficit
disorder, or another of the anxiety disorders. These
coexisting conditions can make OCD difficult to diagnose and
treat.
In addition, symptoms of OCD may be seen in conjunction
with other neurological disorders. People with Tourette's
syndrome, for example, may have an increased rate of OCD.
Scientists now are investigating a hypothesis that a genetic
relationship exists between OCD and such "tic" disorders,
which are characterized by involuntary movements and
vocalizations.
Other illnesses that may be linked to OCD are
trichotillomania (a repeated urge to pull out scalp hair,
eyelashes, eyebrows, or other body hair); body dysmorphic
disorder (excessive preoccupation with imaginary or
exaggerated defects in appearance); and hypochondriasis (fear
of having a serious disease, even though nothing is wrong with
a person). In addition, NIMH researchers are looking at the
possible link of OCD to some autoimmune diseases in which
infection-fighting cells, or antibodies, turn against the body
in an attempt to destroy it.
Most people with OCD know that their obsessions are
unrealistic, but they may sometimes be uncertain about the
validity of their fears or even believe that their fears are
founded. In almost all cases, OCD victims struggle to banish
their unwanted obsessive thoughts and to stop themselves from
engaging in compulsive behaviors.
Many people seem to be able to keep their OCD symptoms
under control at work or school, but resistance may weaken and
then the condition can become so severe that compulsive
rituals take over victims' lives, making it impossible for
them to function normally.
People with OCD often try to hide the condition from
friends and co-workers because they are ashamed of and
confused by their seemingly senseless behaviors. Such feelings
of inadequacy prevent many people from seeking treatment for
the condition. This is regrettable because science has
developed many medications that can help people with OCD.
Pharmacological
TreatmeNT
Many persons with OCD benefit from pharmacological
treatment. Others may be helped by medication in conjunction
with behavioral therapy. Others begin with medication to gain
control over symptoms and then switch to therapy.
In recent years several clinical trials have found that a
number of drugs can affect the neurotransmitter serotonin and
significantly decrease symptoms of OCD. The tricyclic
antidepressant clomipramine (Anafranil) was the first of such
serotonin reuptake inhibitors (SRIs) specifically approved to
treat OCD.
Clomipramine was followed by other SRIs known as "selective
serotonin reuptake inhibitors" (SSRIs). Those approved by the
U.S. Food and Drug Administration to treat OCD include
fluoxetine (Prozac), fluvoxamine (Luvoc), and paroxetine
(Paxil). Several clinical trials suggest that OCD patients may
be helped by sertraline (Zoloft). It can take as long as 10-12
weeks to feel the beneficial effect of high dose SSRI
treatment. This can be a point of frustration for the patient,
but with time, SSRIs have been shown to help patients with
obsessive-compulsive behaviors overcome them.
Such medications have helped, to some degree, in more than
three quarters of patients who took them. In less than half of
patients, the medications helped with a partial reduction in
symptoms. Unfortunately, about only 10-15% of the patients
have a full remission of their symptoms, making the disease
chronic in nature.
If patients do not respond to a medication or they develop
side effects, doctors may try another SRI. Often, if
medications are discontinued, 85% of the patients relapse
within 2 months. If a medication works to alleviate symptoms,
doctors may lower the dosage, but most patients take OCD
medications indefinitely (see more information at the Mental
Health Channel, www.mentalhealthchannel.net/ocd/index.shtml
).
PsychotheraPY
Most OCD patients have not responded well to traditional
psychotherapy, the goal of which is to help people to gain
insight into their problems. But one behavioral therapy that
has worked for many people with OCD is called "exposure and
response prevention." In this approach, the patient
deliberately confronts a feared object or idea. The therapist
then encourages the patient to refrain from ritualizing to
obtain relief. A compulsive hand washer, for example, may be
asked to touch an object believed to be "contaminated," and
may then be urged to avoid washing for several hours, until
the anxiety has decreased.
Most OCD patients who have completed behavioral therapy
have reported a lessening of symptoms. Usually these patients
are highly motivated and have a positive attitude about
treatment. What's more, the therapy appears to have
long-lasting effects. Compulsive rituals have been shown to
improve 70-80% in patients that accept and comply with
therapies such as exposure in vivo and response prevention
(Perse 1988). Another study found that incorporating
relapse-prevention components in a treatment
program--including follow-up sessions after intensive
therapy--contributed to maintenance of improvement (Hiss
1994). One study done in France, where 2-3% of the population
is affected by the disorder, acknowledged that response and
prevention therapy benefits 70% of the patients (Legeron
1989). Group treatment using exposure and response prevention
for obsessive-compulsive disorders was found to be as
effective in a 7-week program as in a 12-week program (Himle
2001).
Another type of psychological treatment,
cognitive-behavioral therapy, may also help some people with
OCD. This form of therapy attempts to change beliefs and
thinking patterns of people with OCD. More studies are needed
to evaluate the effects of cognitive-behavioral therapy.
Many people may believe religious beliefs shouldn't have a
part in psychiatry, but according to Dr. Gangdev of the
Community Mental Health Service in the Tokoroa Hospital of New
Zealand, strong religious beliefs may play a role in treating
psychiatric disorders. Gangdev treated a woman with doubt
obsessions in a single session using a positive religious
affirmation. This form of treatment is called cognitive
restructuring and thought-stopping. Stated Gangdev, "although
unusual in standard clinical practice, rapid resolution of
obsessions is possible." The woman remained well for 5 months,
but was lost to follow-up (Gangdev 1998).
Other TherapiES
Scientists are investigating the potential of neurosurgery,
a new approach to treating OCD. In the few centers where
neurosurgery has been performed, the treatment has been
recommended only for people who have failed to respond to
conventional medications or psychotherapy (Nemeth 1998).
There have been several published anecdotal reports of the
successful use of electroconvulsive therapy (ECT) in OCD
patients (Wohlfahrt 1996). Most often, however, benefits of
ECT have been short-lived (Khanna 1988). The treatment
generally is restricted to people with treatment-resistant OCD
accompanied by severe depression (Maletzky 1994; Schott
1992).
Natural TreatmenTS
Some naturopathic physicians have reported success in
treating OCD with a variety of natural therapies.
Certain herbs and supplements act directly on the nervous
system, promoting relaxation and feelings of tranquillity.
Others may relax tense muscles, ease stress-related headaches,
soothe stomachs upset by stress, and encourage restful
sleep.
L-Theanine
L-Theanine is an amino acid derived from green tea. Theanine
readily crosses the blood-brain barrier of humans and exerts
subtle changes in biochemistry. An increase in alpha waves has
been documented. One of the things that theanine changes is
GABA, a brain chemical known for its calming effect. Theanine
increases GABA. Theanine also increases levels of dopamine,
another brain chemical with mood-enhancing effects. Theanine
reduces stress which is directly connected to the intensity of
OCD episodes (Kakuda et al. 2000).
Inositol
Inositol (myo-inositol) is required for proper formation of
cell membranes, where it functions as phosphatidylinositol. It
affects nerve transmission and helps in transporting fats
within the body and also facilitates the action of many
methylating agents. Inositol is important in reproduction,
embryogenesis, and neural tube defects. It also stimulates the
production of lung surfactant, which is extremely important in
the newborn. Inositol has been recognized in the past for its
combined effect with choline as part of lecithin. Having a
lowered or altered production of inositol has been associated
with adult onset diabetes, multiple sclerosis, premature
retinopathy, fatty liver, chronic renal failure, depression,
panic disorders, and OCD.
In a 1997 report entitled "Controlled Trials of Inositol in
Psychiatry" published in the Journal of the European College
of Neuropsychopharmacology, Levine reported the effects of
inositol on many disorders in which it had been studied.
Inositol is reported to reverse desensitization of serotonin
receptors; this is important because serotonin reuptake
inhibitors are known to benefit obsessive-compulsive
disorders. Thirteen patients in a double-blind controlled
crossover trial were each given 18 grams a day or a placebo
for 6 weeks. Researchers found that inositol significantly
reduced scores of obsessive-compulsive symptoms compared to
placebo (Levine 1997).
Tryptophan
Tryptophan is an essential amino acid found in cheeses,
peanuts, milk, and meat sources. Tryptophan is the only
precursor to the neurotransmitter serotonin. Serotonin helps
induce sleep and tranquility and helps to fight depression.
Vitamin B6 is necessary for the synthesis of tryptophan into
serotonin.
Patients that have treatment-resistant OCD may benefit from
sequential administration of tryptophan to increase levels of
serotonin. In one study, OCD patients who were resistant to
SRIs were given the beta-adrenergic antagonist pindolol, which
led to an improvement in depressive symptoms but did not alter
the OCD symptomatology. Tryptophan was then added to the
administration of pindolol, producing a significant
improvement after 4 weeks, and even more improvement at 6
weeks (36% decrease of the Yale-Brown Obsessive Compulsive
Score). The improvement was maintained with treatment
prolongation (Blier 1996). Another study done in Italy,
however, showed no improvement in OCD with the administration
of tryptophan (Smeraldi 1996).
In another controlled study, Huwig-Poppe used a tryptophan
depletion test on OCD and normal healthy subjects to evaluate
the effect serotonin has on sleep patterns. He found that
depletion of tryptophan led to more noticeable disturbances in
the continuity of sleep in the OCD patients than in the
healthy subjects, indicating there was an increase in wake
time and a decrease in the total sleep time for the OCD
patients. In both groups there was a decrease of total sleep
time. The results led to the conclusion that there is an
important role of the serotonergic system for sleep
maintenance and the phasic aspects of REM sleep (Huwig-Poppe
1999).
Other TherapiES
Exercise
Canadian researchers report that regular exercise may help
many people who suffer from psychiatric disorders, including
phobias and OCD. Researchers Gregg A. Tkachuk and Garry L.
Martin of the Department of Psychology at the University of
Manitoba in Winnipeg examined studies of anxiety disorder and
exercise dating back to 1981. They found that strength
training, running, walking, and other forms of aerobic
exercise help to alleviate mild to moderate depression and may
also help to treat other mental disorders including anxiety
and substance abuse.
SUMMARY
Research indicates that biological factors and/or cognitive
processes may cause or contribute to OCD. OCD sufferers,
therefore, respond well to medications that alter brain
chemistry. Some natural therapies that act directly on the
central nervous system may lessen the symptoms of OCD or the
precipitating anxiety (see the Anxiety and Stress
protocol for more information on anxiety disorders).
- L-theanine has a calming
effect and may help decrease symptoms of anxiety, 200 mg,
twice a day.
- Inositol (myo-inositol) may
reverse desensitization of serotonin receptors leading to
improvement of OCD symptoms. For OCD and panic disorders, 4
grams in 3 divided doses a day is recommended.
- Tryptophan may help increase
levels of the neurotransmitter serotonin. Two grams should be
given in the evening on an empty stomach.
For more informatiON
Contact the National Mental Health Association, (800)
969-6642.
Product availabiliTY
L-theanine
and inositol
are available from the Life Extension Foundation by calling
(800) 544-4440 or by ordering online. Ask the Foundation to
provide you with a list of knowledgeable physicians in your
area who will prescribe clomipramine and other drugs to treat
OCD.
|